Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2024 Earnings Call Transcript February 27, 2025
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.1.
Operator: My name is Kathleen, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Fourth Quarter 2024 Investor Update Conference Call. All lines have been placed on mute to prevent any background noise. After...
